ISRCTN88773338已完成3 期
A randomised phase III trial of preoperative chemoradiation versus chemoradiation with weekly cisplatin/gemcitabine in FIGO stages IB2-IIB
ational Cancer Institute of Mexico (Instituto Nacional de Cancerologia)0 个研究点目标入组 211 人开始时间: 2005年6月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 211
研究概览
简要总结
2013 results in: https://www.ncbi.nlm.nih.gov/pubmed/23609186 (added 03/05/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically confirmed squamous, adenosquamous or adenocarcinoma
- •2. Untreated
- •3. International Federation of Gynecology and Obstetrics (FIGO) staged IB2, IIA and IIB
- •4. Mesurable disease
- •5. Aged 18 to 70 years
- •6. Zero to two World Health Organisation (WHO) status performance
- •7. Normal renal, hepatic and hematological function
- •8. Negative pregnancy test or biological inability to become pregnant
- •9. Informed consent
排除标准
- •1. Systemic and/or uncontrolled disease that preclude the use of chemotherapy
- •2. Pre-existent or concurrent neuropathy of any cause
- •3. Mental disease
- •4. Previous malignancy except non-melanoma skin cancer
研究者
相似试验
撤回
3 期
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung CancerCarcinoma, Non-Small-Cell LungNCT00329472Samsung Medical Center
已完成
不适用
A phase III randomised trial of sequential chemotherapy followed by radical radiotherapy versus concurrent chemo-radiotherapy followed by chemotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer (NSCLC) and good performance status.on Small Cell Lung Cancer (NSCLC)Lung cancerCancerISRCTN13746987Sponsor not defined - Record provided by CRUK and UCL CTC (UK)508
招募中
3 期
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaRetroperitoneal SarcomaLiposarcomaLeiomyosarcomaNCT04031677European Organisation for Research and Treatment of Cancer - EORTC250
已完成
3 期
Concomitant chemoradiotherapy for treatment of non-small cell lung cancer - the Conrad studyCancerISRCTN63778716Pierre Fabre Pharma Norden AB (Sweden)352
已完成
3 期
A phase III multi-centre randomised controlled trial to assess whether optimal supportive care alone (including dexamethasone) is as effective as optimal supportive care (including dexamethasone) plus whole brain radiotherapy in the treatment of patients with inoperable brain metastases from non-small cell lung canceron-small cell lung cancer with inoperable brain metastasesLung cancerCancerISRCTN13826061Medical Research Council (MRC) (UK)534